Structure and Mechanism of Iodothyronine Deiodinases – What We Know, What We Don’t Know, and What Would Be Nice to Know

Abstract

Deiodinases catalyze the specific removal of iodine atoms from one of the two iodinated phenyl rings in iodothyronines. They thereby fine-regulate local thyroid hormone concentrations in organs or cells. The chemical reaction is unique in the sense that in metazoans the reductive elimination of iodide depends on the rare amino acid selenocysteine in the enzymes’ active centers. While there is no prokaryotic homologue of such deiodinases, the solution of the crystal structure of a catalytic domain of mouse deiodinase 3 has revealed that the ancient peroxiredoxin structure has been repurposed, and improved using selenocysteine, as a deiodinase during metazoan evolution. Likewise, many biochemical findings obtained over decades can now be interpreted in light of the molecular structure. Despite this leap in our understanding of deiodinase structure, there are still several open questions that need to be addressed in order to fully understand substrate binding, catalytic mechanism, and regulation of deiodinases. We surmise that these issues as well as differences between the three highly homologous isoenzymes must be understood in order to develop modulators of deiodinases that could be valuable in clinical use.

Key words

thyroid hormone - metabolism - dehalogenation - catalysis

Publication History

Received: 27 August 2019
Received: 25 September 2019

Accepted: 07 October 2019

Article published online:
07 November 2019

• References

• 1 Bianco AC, Kim BW. Deiodinases: Implications of the local control of thyroid hormone action. J Clin Invest 2006; 116: 2571-2579
• 2 Mullur R, Liu YY, Brent GA. Thyroid hormone regulation of metabolism. Physiol Rev 2014; 94: 355-382. DOI: 10.1152/physrev.00030.2013.
• 3 Schweizer U, Steegborn C. New insights into the structure and mechanism of iodothyronine deiodinases. J Mol Endocrinol 2015; 55: R37-R52 DOI: 10.1530/JME-15-0156.
• 4 Dentice M, Marsili A, Zavacki A. et al. The deiodinases and the control of intracellular thyroid hormone signaling during cellular differentiation. Biochim Biophys Acta 2013; 1830: 3937-3945 DOI: 10.1016/j.bbagen.2012.05.007.
• 5 Ciavardelli D, Bellomo M, Crescimanno C. et al. Type 3 deiodinase: role in cancer growth, stemness, and metabolism. Front Endocrinol 2014; 5: 215 DOI: 10.3389/fendo.2014.00215.
• 6 Dentice M, Antonini D, Salvatore D. Type 3 deiodinase and solid tumors: An intriguing pair. Expert Opin Ther Targets 2013; 17: 1369-1379. DOI: 10.1517/14728222.2013.833189.
• 7 Bommer M, Kunze C, Fesseler J. et al. Structural basis for organohalide respiration. Science 2014; 346: 455-458 DOI: 10.1126/science.1258118.
• 8 Payne KA, Quezada CP, Fisher K. et al. Reductive dehalogenase structure suggests a mechanism for B12-dependent dehalogenation. Nature 2015; 517: 513-516 DOI: 10.1038/nature13901.
• 9 Sun Z, Su Q, Rokita SE. The distribution and mechanism of iodotyrosine deiodinase defied expectations. Arch Biochem Biophys 2017; 632: 77-87 DOI: 10.1016/j.abb.2017.07.019.
• 10 Manna D, Mondal S, Mugesh G. Halogen bonding controls the regioselectivity of the deiodination of thyroid hormones and their sulfate analogues. Chemistry 2015; 21: 2409-2416 DOI: 10.1002/chem.201405442.
• 11 Schweizer U, Schlicker C, Braun D. et al. The crystal structure of mammalian selenocysteine-dependent iodothyronine deiodinase suggests a peroxiredoxin-like catalytic mechanism. Proc Natl Acad Sci USA 2014; 111: 10526-10531. DOI: 10.1073/pnas.1323873111.
• 12 Callebaut I, Curcio-Morelli C, Mornon JP. et al. The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J Biol Chem 2003; 278: 36887-36896. DOI: 10.1074/jbc.M305725200.
• 13 Schweizer U, Towell H, Vit A. et al. Structural aspects of thyroid hormone binding to proteins and competitive interactions with natural and synthetic compounds. Mol Cell Endocrinol 2017; 458: 57-67 DOI: 10.1016/j.mce.2017.01.026.
• 14 Bayse CA, Rafferty ER. Is halogen bonding the basis for iodothyronine deiodinase activity?. Inorg Chem 2010; 49: 5365-5367 DOI: 10.1021/ic100711n.
• 15 Flohé L, Toppo S, Cozza G. et al. A comparison of thiol peroxidase mechanisms. Antioxid Redox Signal 2011; 15: 763-780. DOI: 10.1089/ars.2010.3397.
• 16 Zhong L, Arner ES, Holmgren A. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc Natl Acad Sci USA 2000; 97: 5854-5859 DOI: 10.1073/pnas.100114897.
• 17 Koh CS, Didierjean C, Navrot N. et al. Crystal structures of a poplar thioredoxin peroxidase that exhibits the structure of glutathione peroxidases: insights into redox-driven conformational changes. J Mol Biol 2007; 370: 512-529 DOI: 10.1016/j.jmb.2007.04.031.
• 18 Fortino M, Marino T, Russo N. et al. Mechanism of thyroxine deiodination by naphthyl-based iodothyronine deiodinase mimics and the halogen bonding role: A DFT investigation. Chemistry 2015; 21: 8554-8560 DOI: 10.1002/chem.201406466.